{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:03:33Z","timestamp":1790186613318,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.xops.2025.100834","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T12:20:10Z","timestamp":1748262010000},"page":"100834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Incidence and Clinical Practice of Myopic Macular Neovascularization: A Nationwide Population-Based Cohort Study"],"prefix":"10.1016","volume":"5","author":[{"given":"Masahiro","family":"Akada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7410-3764","authenticated-orcid":false,"given":"Masahiro","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Kido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakako","family":"Okayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Morino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Yasukura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitaka","family":"Tsujikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2025.100834_bib1","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/S0140-6736(12)60272-4","article-title":"Myopia","volume":"379","author":"Morgan","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.xops.2025.100834_bib2","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1167\/iovs.13-12795","article-title":"The economic cost of myopia in adults aged over 40 years in Singapore","volume":"54","author":"Zheng","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100834_bib3","first-page":"2486","article-title":"Prevalence and risk factors for refractive errors in adult Chinese in Singapore","volume":"41","author":"Wong","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100834_bib4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2007.03.075","article-title":"Refractive errors in an elderly Japanese population: the Tajimi Study","volume":"115","author":"Sawada","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100834_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10384-023-00991-y","article-title":"Epidemiological investigation of the status of myopia in children and adolescents in Fujian Province in 2020","volume":"67","author":"Lin","year":"2023","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100834_bib6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ophtha.2020.08.023","article-title":"Myopia prevalence and ocular biometry features in a general Japanese population: the Nagahama Study","volume":"128","author":"Nakao","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100834_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/bjo.87.5.570","article-title":"Patchy atrophy and lacquer cracks predispose to the development of macular neovascularisation in pathological myopia","volume":"87","author":"Ohno-Matsui","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100834_bib8","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/s41467-018-03649-3","article-title":"CCDC102B confers risk of low vision and blindness in high myopia","volume":"9","author":"Hosoda","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.xops.2025.100834_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107923","article-title":"Analysis of fundus shape in highly myopic eyes by using curvature maps constructed from optical coherence tomography","volume":"9","author":"Miyake","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2025.100834_bib10","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1167\/iovs.13-12280","article-title":"Evaluation of pigment epithelium-derived factor and complement factor I polymorphisms as a cause of choroidal neovascularization in highly myopic eyes","volume":"54","author":"Miyake","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100834_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ophtha.2013.06.043","article-title":"Vascular endothelial growth factor gene and the response to anti-vascular endothelial growth factor treatment for choroidal neovascularization in high myopia","volume":"121","author":"Miyake","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100834_bib12","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1167\/iovs.11-9405","article-title":"Vascular endothelial growth factor gene polymorphisms and choroidal neovascularization in highly myopic eyes","volume":"53","author":"Akagi-Kurashige","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100834_bib13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.oret.2024.09.016","article-title":"Genome-wide meta-analysis for myopic macular neovascularization identified a novel susceptibility locus and revealed a shared genetic susceptibility with age-related macular degeneration","volume":"9","author":"Morino","year":"2025","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2025.100834_bib14","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0161-6420(01)01007-7","article-title":"Long-term visual prognosis of macular neovascularization in high myopia: a comparison between age groups","volume":"109","author":"Yoshida","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100834_bib15","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0161-6420(03)00461-5","article-title":"Myopic macular neovascularization: a 10-year follow-up","volume":"110","author":"Yoshida","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100834_bib16","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ophtha.2017.02.018","article-title":"Treatment patterns for myopic macular neovascularization in the United States: analysis of the IRIS registry","volume":"124","author":"Willis","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100834_bib17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ajo.2010.09.021","article-title":"Intravitreal ranibizumab for myopic macular neovascularization: factors predictive of visual outcome and need for retreatment","volume":"151","author":"Calvo-Gonzalez","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100834_bib18","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/IAE.0b013e3181b1bb1a","article-title":"Anti-VEGF drugs as the 2009 first-line therapy for macular neovascularization in pathologic myopia","volume":"29","author":"Cohen","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.xops.2025.100834_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/IAE.0b013e3181bcef24","article-title":"Intravitreal ranibizumab for macular neovascularization complicating pathologic myopia","volume":"30","author":"Lalloum","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.xops.2025.100834_bib20","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1097\/IAE.0b013e3181e22659","article-title":"Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic macular neovascularization","volume":"30","author":"Ruiz-Moreno","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.xops.2025.100834_bib21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/bjo.2009.174243","article-title":"Is ranibizumab effective in stopping the loss of vision for macular neovascularisation in pathologic myopia? A long-term follow-up study","volume":"95","author":"Vadal\u00e0","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100834_bib22","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/IAE.0b013e31827d260a","article-title":"Intravitreal anti-vascular endothelial growth factor for macular neovascularization secondary to pathologic myopia: systematic review and meta-analysis","volume":"33","author":"Wang","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.xops.2025.100834_bib23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ophtha.2013.10.023","article-title":"RADIANCE: a randomized controlled study of ranibizumab in patients with macular neovascularization secondary to pathologic myopia","volume":"121","author":"Wolf","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100834_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ajo.2013.08.010","article-title":"Epidemiology and disease burden of pathologic myopia and myopic macular neovascularization: an evidence-based systematic review","volume":"157","author":"Wong","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100834_bib25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s10384-023-00986-9","article-title":"A nationwide survey of newly certified visually impaired individuals in Japan for the fiscal year 2019: impact of the revision of criteria for visual impairment certification","volume":"67","author":"Matoba","year":"2023","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100834_bib26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10384-016-0496-3","article-title":"Epidemiology, treatment pattern and health care utilization of myopic macular neovascularization: a population-based study","volume":"61","author":"Yang","year":"2017","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100834_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/opo.12456","article-title":"Five-year incidence and progression of myopic maculopathy in a rural Chinese adult population: the Handan Eye Study","volume":"38","author":"Lin","year":"2018","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.xops.2025.100834_bib28","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.ophtha.2017.04.028","article-title":"Myopic choroidal neovascularization: review, guidance, and consensus statement on management","volume":"124","author":"Cheung","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100834_bib29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.preteyeres.2017.10.005","article-title":"Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia","volume":"63","author":"Ohno-Matsui","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2025.100834_bib30","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2147\/OPTH.S311816","article-title":"Real-world anti-vascular endothelial growth factor therapy outcomes in myopic choroidal neovascularization","volume":"15","author":"Bhatia","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.xops.2025.100834_bib31","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1177\/1120672120963455","article-title":"Three-year real-world outcomes of intravitreal anti-VEGF therapies in patients affected by myopic choroidal neovascularization","volume":"31","author":"Corazza","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100834_bib32","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2023.38.e174","article-title":"Real-world treatment intensity and patterns in patients with myopic choroidal neovascularization: common data model in ophthalmology","volume":"38","author":"Bui","year":"2023","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.xops.2025.100834_bib33","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1038\/s41433-018-0192-2","article-title":"Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan","volume":"32","author":"Ohno-Matsui","year":"2018","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2025.100834_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227557","article-title":"Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: results from the LUMINOUS study","volume":"15","author":"Hamilton","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2025.100834_bib35","first-page":"143e150","article-title":"History of the secondary use of national database of health insurance claims and specific health checkups of Japan (NDB)","volume":"55","author":"Kato","year":"2017","journal-title":"Trans Jpn Soc Med Biol Eng"},{"key":"10.1016\/j.xops.2025.100834_bib36","doi-asserted-by":"crossref","first-page":"303e305","DOI":"10.1111\/iju.13840","article-title":"Regional clinical practice variation in urology: usage example of the open data of the national database of health insurance claims and specific health checkups of Japan","volume":"26","author":"Sugihara","year":"2019","journal-title":"Int J Urol"},{"key":"10.1016\/j.xops.2025.100834_bib37","doi-asserted-by":"crossref","first-page":"13e26","DOI":"10.37737\/ace.2.1_13","article-title":"A review of studies using the Japanese national database of health insurance claims and specific health checkups","volume":"2","author":"Hirose","year":"2020","journal-title":"Ann Clin Epidemiol"},{"key":"10.1016\/j.xops.2025.100834_bib38","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1136\/bjophthalmol-2021-319403","article-title":"Incidence of central serous chorioretinopathy (2011\u20132018): a nationwide population-based cohort study of Japan","volume":"106","author":"Kido","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100834_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100125","article-title":"Incidence and clinical practice of exudative age-related macular degeneration: a nationwide population-based cohort study","volume":"2","author":"Kido","year":"2022","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.xops.2025.100834_bib40","doi-asserted-by":"crossref","first-page":"373e380","DOI":"10.1016\/j.je.2016.08.010","article-title":"Epidemiology of overdose episodes from the period prior to hospitalization for drug poisoning until discharge in Japan: an exploratory descriptive study using a nationwide claims database","volume":"27","author":"Okumura","year":"2017","journal-title":"J Epidemiol"},{"issue":"3","key":"10.1016\/j.xops.2025.100834_bib41","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ophtha.2021.09.011","article-title":"Incidence of sympathetic ophthalmia after inciting events: a national database study in Japan","volume":"129","author":"Hashimoto","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100834_bib42","article-title":"National database of health insurance claims and specific health checkups of Japan (NDB): outline and patient-matching technique","author":"Kubo","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.xops.2025.100834_bib44","first-page":"10","article-title":"Age standardization of rates: a new WHO standard","volume":"31","author":"Ahmad","year":"2001","journal-title":"GPE Discussion Paper Series"},{"key":"10.1016\/j.xops.2025.100834_bib45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s41065-020-00162-w","article-title":"Population genomics of East Asian ethnic groups","volume":"157","author":"Pan","year":"2020","journal-title":"Hereditas"},{"key":"10.1016\/j.xops.2025.100834_bib46","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.survophthal.2017.03.006","article-title":"Myopia among schoolchildren in east Asia and Singapore","volume":"62","author":"Ding","year":"2017","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.xops.2025.100834_bib47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/17571472.2010.11493315","article-title":"An overview of the healthcare system in Taiwan","volume":"3","author":"Wu","year":"2010","journal-title":"Lond J Prim Care (Abingdon)"},{"key":"10.1016\/j.xops.2025.100834_bib48","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.dsx.2020.06.042","article-title":"Impact of COVID-19 on routine care for chronic diseases: a global survey of views from healthcare professionals","volume":"14","author":"Chudasama","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.xops.2025.100834_bib49","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/fampra\/cmac016","article-title":"Impact of state of emergency for coronavirus disease 2019 on hospital visits and disease exacerbation: the Japan COVID-19 and Society Internet Survey","volume":"39","author":"Yoshida","year":"2022","journal-title":"Fam Pract"},{"key":"10.1016\/j.xops.2025.100834_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100729","article-title":"Annual trend of myopia and high myopia in children in Japan: a nationwide claims database study","volume":"5","author":"Kamei","year":"2025","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.xops.2025.100834_bib51","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00006982-200208000-00004","article-title":"Expression of estrogen receptor in the choroidal neovascular membranes in highly myopic eyes","volume":"22","author":"Kobayashi","year":"2002","journal-title":"Retina"},{"key":"10.1016\/j.xops.2025.100834_bib52","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00417-023-06271-2","article-title":"Treatment of myopic macular neovascularization: a network meta-analysis and review","volume":"262","author":"Glachs","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.xops.2025.100834_bib53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10384-022-00969-2","article-title":"Recent trends in anti-vascular endothelial growth factor intravitreal injections: a large claims database study in Japan","volume":"67","author":"Hashimoto","year":"2023","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100834_bib54","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1007\/s40123-024-01011-z","article-title":"Cost-effectiveness analysis of ranibizumab biosimilar for neovascular age-related macular degeneration and its subtypes from the societal and patient perspectives in Japan","volume":"13","author":"Yanagi","year":"2024","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.xops.2025.100834_bib55","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jamaophthalmol.2020.5053","article-title":"Efficacy and safety of a proposed ranibizumab biosimilar product vs a reference ranibizumab product for patients with neovascular age-related macular degeneration: a randomized clinical trial","volume":"139","author":"Woo","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2025.100834_bib56","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.3390\/jcm13164641","article-title":"One-year outcome of intravitreal injection of ranibizumab biosimilar for myopic choroidal neovascularization in Japanese patients","volume":"13","author":"Tomita","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.xops.2025.100834_bib57","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41433-022-02246-5","article-title":"Approved biosimilar ranibizumab\u2014a global update","volume":"37","author":"Sharma","year":"2023","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2025.100834_bib58","article-title":"Effects of reimbursement add-on policies on trastuzumab and bevacizumab biosimilar adoption in a Japanese oncology setting","volume":"46","author":"Mamiya","year":"2025","journal-title":"Value Health Reg Issues"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525001320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525001320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T21:12:41Z","timestamp":1772053961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914525001320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2666914525001320"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2025.100834","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Clinical Practice of Myopic Macular Neovascularization: A Nationwide Population-Based Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2025.100834","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100834"}}